John W. Rollins

Array ( [id] => 3587724 [patent_doc_number] => 05552440 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-03 [patent_title] => 'Use of L-canavanine as a chemotherapeutic agent for the treatment of pancreatic cancer' [patent_app_type] => 1 [patent_app_number] => 8/353270 [patent_app_country] => US [patent_app_date] => 1994-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 4649 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/552/05552440.pdf [firstpage_image] =>[orig_patent_app_number] => 353270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3494136 [patent_doc_number] => 05561165 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-01 [patent_title] => 'Method for treating insulin resistance' [patent_app_type] => 1 [patent_app_number] => 8/347884 [patent_app_country] => US [patent_app_date] => 1994-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4828 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/561/05561165.pdf [firstpage_image] =>[orig_patent_app_number] => 347884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3623198 [patent_doc_number] => 05602111 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-11 [patent_title] => 'Agent for inducing phytoalexin and method for inducing phytoalexin' [patent_app_type] => 1 [patent_app_number] => 8/343453 [patent_app_country] => US [patent_app_date] => 1994-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4120 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/602/05602111.pdf [firstpage_image] =>[orig_patent_app_number] => 343453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3642644 [patent_doc_number] => 05637301 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-10 [patent_title] => 'Obtention of ice nucleating agent from sea buckthorn' [patent_app_type] => 1 [patent_app_number] => 8/344210 [patent_app_country] => US [patent_app_date] => 1994-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4698 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/637/05637301.pdf [firstpage_image] =>[orig_patent_app_number] => 344210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3562022 [patent_doc_number] => 05525594 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-11 [patent_title] => 'Treatment of hyperandrogenic disorders' [patent_app_type] => 1 [patent_app_number] => 8/340025 [patent_app_country] => US [patent_app_date] => 1994-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4339 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/525/05525594.pdf [firstpage_image] =>[orig_patent_app_number] => 340025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3634472 [patent_doc_number] => 05610189 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-11 [patent_title] => 'Disinfecting composition' [patent_app_type] => 1 [patent_app_number] => 8/295741 [patent_app_country] => US [patent_app_date] => 1994-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4470 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/610/05610189.pdf [firstpage_image] =>[orig_patent_app_number] => 295741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3577951 [patent_doc_number] => 05523490 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-04 [patent_title] => 'Illudin analogs' [patent_app_type] => 1 [patent_app_number] => 8/332940 [patent_app_country] => US [patent_app_date] => 1994-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 8324 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/523/05523490.pdf [firstpage_image] =>[orig_patent_app_number] => 332940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3558270 [patent_doc_number] => 05500368 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-19 [patent_title] => 'Finely divided anthraquinone formulations as inhibitors of sulfide production from sulfate-reducing bacteria' [patent_app_type] => 1 [patent_app_number] => 8/327331 [patent_app_country] => US [patent_app_date] => 1994-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3137 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/500/05500368.pdf [firstpage_image] =>[orig_patent_app_number] => 327331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3646554 [patent_doc_number] => 05629194 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-13 [patent_title] => 'Isolated porcine pancreatic cells for use in treatment of diseases characterized by insufficient insulin activity' [patent_app_type] => 1 [patent_app_number] => 8/327506 [patent_app_country] => US [patent_app_date] => 1994-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 12850 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/629/05629194.pdf [firstpage_image] =>[orig_patent_app_number] => 327506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3598336 [patent_doc_number] => 05578307 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-26 [patent_title] => 'Shaped articles containing plant extract(s), in particular pellets, and their pharmaceutical or cosmetic use' [patent_app_type] => 1 [patent_app_number] => 8/256651 [patent_app_country] => US [patent_app_date] => 1994-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8023 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/578/05578307.pdf [firstpage_image] =>[orig_patent_app_number] => 256651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3660357 [patent_doc_number] => 05627271 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-06 [patent_title] => 'Glycolipids, their preparation and use' [patent_app_type] => 1 [patent_app_number] => 8/318758 [patent_app_country] => US [patent_app_date] => 1994-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4240 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/627/05627271.pdf [firstpage_image] =>[orig_patent_app_number] => 318758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3509314 [patent_doc_number] => 05563065 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-08 [patent_title] => 'Controlling growth of filamentous microorganisms' [patent_app_type] => 1 [patent_app_number] => 8/244859 [patent_app_country] => US [patent_app_date] => 1994-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 3242 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/563/05563065.pdf [firstpage_image] =>[orig_patent_app_number] => 244859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3578365 [patent_doc_number] => 05498412 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-12 [patent_title] => 'Antioxidant composition and method for the same' [patent_app_type] => 1 [patent_app_number] => 8/322013 [patent_app_country] => US [patent_app_date] => 1994-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4015 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 310 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/498/05498412.pdf [firstpage_image] =>[orig_patent_app_number] => 322013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3602674 [patent_doc_number] => 05578590 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-26 [patent_title] => 'Pharmaceutical composition preparation for use in inhibiting protein kinase C' [patent_app_type] => 1 [patent_app_number] => 8/319478 [patent_app_country] => US [patent_app_date] => 1994-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3968 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/578/05578590.pdf [firstpage_image] =>[orig_patent_app_number] => 319478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3697024 [patent_doc_number] => 05674488 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'Method for prevention and treatment of hyperchlolesterolemia by in vivo hydrogenation of cholesterol' [patent_app_type] => 1 [patent_app_number] => 8/319818 [patent_app_country] => US [patent_app_date] => 1994-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5048 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/674/05674488.pdf [firstpage_image] =>[orig_patent_app_number] => 319818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3548990 [patent_doc_number] => 05545731 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-13 [patent_title] => 'Alkyl and/or alkenyl oligoglycoside carbonates' [patent_app_type] => 1 [patent_app_number] => 8/313178 [patent_app_country] => US [patent_app_date] => 1994-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1894 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 177 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/545/05545731.pdf [firstpage_image] =>[orig_patent_app_number] => 313178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1486285 [patent_doc_number] => 06365787 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-02 [patent_title] => 'Compounds for the suppression of HIV TAT transactivation' [patent_app_type] => B1 [patent_app_number] => 08/316341 [patent_app_country] => US [patent_app_date] => 1994-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 2 [patent_no_of_words] => 6709 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/365/06365787.pdf [firstpage_image] =>[orig_patent_app_number] => 08316341 [rel_patent_id] =>[rel_patent_doc_number] =>)